Although the activation of either TMM seems to be equivalent in supporting the limitless proliferative potential of tumor cells, the contribution of telomerase activity and ALT to tumor progression, hence to patients’ outcome, has been reported to differ prominently [15]. The gene discussed is GPT; the disease is neoplasm.